Back

Leveraging the shared and opposing genetic mechanisms in the heritable cardiomyopathies for gene discovery

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Improved understanding of the genetic background of cardiomyopathy Dilated Cardiomyopathy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Daria Kramarenko

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
The impact of desmosomal mutations on clinical features in arrhythmogenic cardiomyopathy: towards tailored arrhythmic risk stratification
Doctor M. Martini (Padova, IT)
Abstract Slides
Presentation thumbnail
Predictors of the identification of clinically relevant genetic variants in dilated cardiomyopathy in a sample of the brazilian population
Mr L. Cedro (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Identification of ultra-rare variants in dilated cardiomyopathy: insights into LMNA pathogenesis and prognostic significance
Doctor T. Kitai (Suita, JP)
Abstract Slides
Presentation thumbnail
Gain-of-function vs. loss-of-function effects of DES variants on cardiodesminopathy phenotypes
Mr M. Urtis (Pavia, IT)
Abstract Slides
Presentation thumbnail
The clinical spectrum of TTN variants in families affected by dilated cardiomyopathy: evidence for a pre-clinical phenotype
Doctor F. Goldie (Glasgow, GB)
Abstract Slides

Access the full session

Session thumbnail
Improved understanding of the genetic background of cardiomyopathy
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Polygenic risk scores in dilated cardiomyopathy: associations with arrhythmic events and implications for clinical research
thumbnail
Congress Presentation
Utility of polygenic risk score for prediction of dilated cardiomyopathy and modulation of severity of LV dysfunction among cases
thumbnail
Congress Presentation
Genetic and drug repurposing insights into hypertrophic cardiomyopathy: a machine learning approach

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources